Position in GILD
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$7,365,242
-$11,378,350 QoQ
Shares Held
58,297
-56.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#494
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. GILD ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,365,242 | 58,297 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $18,743,592 | 134,488 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $9,780,659 | 79,686 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,204,232 | 73,912 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,815,558 | 70,493 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $7,691,896 | 68,647 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $5,938,190 | 64,287 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,113,150 | 60,987 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $3,117,775 | 45,442 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $3,507,796 | 47,888 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,796,452 | 46,864 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,936,448 | 39,184 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $4,546,744 | 58,995 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,694,774 | 56,584 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $735,992 | 8,573 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $474,025 | 7,684 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,215,764 | 35,848 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,940,507 | 32,641 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,701,600 | 37,207 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,635,273 | 52,044 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,535,547 | 51,344 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $3,108,056 | 48,090 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $102,362 | 1,757 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $63,821 | 1,010 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $66,937 | 870 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $60,779 | 813 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||